CD9 and hepatocellular carcinoma: Consistently, our results of qPCR and western blot analyses also found that reduced expression of CD9 and CD81 activates the JNK pathway, as well as enhances the expression of cyclin D1 and Bcl-2, which in turn promoted HCC cell proliferation and anti-apoptosis.